J. Kerdraon

2.3k total citations
89 papers, 1.1k citations indexed

About

J. Kerdraon is a scholar working on Urology, Rheumatology and Surgery. According to data from OpenAlex, J. Kerdraon has authored 89 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Urology, 44 papers in Rheumatology and 19 papers in Surgery. Recurrent topics in J. Kerdraon's work include Pelvic floor disorders treatments (44 papers), Urinary Bladder and Prostate Research (39 papers) and Botulinum Toxin and Related Neurological Disorders (15 papers). J. Kerdraon is often cited by papers focused on Pelvic floor disorders treatments (44 papers), Urinary Bladder and Prostate Research (39 papers) and Botulinum Toxin and Related Neurological Disorders (15 papers). J. Kerdraon collaborates with scholars based in France, Switzerland and United States. J. Kerdraon's co-authors include G. Amarenco, P. Denys, Samer Sheikh Ismaël, X. Gamé, G. Karsenty, François Haab, A. Ruffion, A. Even-Schneider, B. Parratte and B. Perrouin-Verbe and has published in prestigious journals such as The Journal of Urology, European Urology and Clinical Neurophysiology.

In The Last Decade

J. Kerdraon

80 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Kerdraon France 16 764 731 309 177 147 89 1.1k
Samer Sheikh Ismaël France 16 542 0.7× 580 0.8× 300 1.0× 151 0.9× 49 0.3× 58 897
Richard Baverstock Canada 15 506 0.7× 457 0.6× 276 0.9× 182 1.0× 74 0.5× 57 890
H.E. Dijkema Netherlands 10 1.1k 1.4× 998 1.4× 351 1.1× 189 1.1× 69 0.5× 14 1.3k
Marianne de Sèze France 13 1.3k 1.7× 1.0k 1.4× 185 0.6× 268 1.5× 408 2.8× 18 1.6k
Rose Khavari United States 17 393 0.5× 399 0.5× 230 0.7× 92 0.5× 79 0.5× 90 757
F. Le Breton France 12 315 0.4× 303 0.4× 121 0.4× 126 0.7× 123 0.8× 87 642
J.-J. Labat France 15 266 0.3× 317 0.4× 343 1.1× 85 0.5× 79 0.5× 82 848
Ubi van den Hombergh Netherlands 12 1.2k 1.5× 1.1k 1.6× 494 1.6× 200 1.1× 65 0.4× 22 1.4k
M Perrigot France 14 283 0.4× 293 0.4× 284 0.9× 73 0.4× 131 0.9× 52 736
G. Krämer Germany 16 1.7k 2.2× 1.3k 1.8× 273 0.9× 394 2.2× 521 3.5× 46 2.0k

Countries citing papers authored by J. Kerdraon

Since Specialization
Citations

This map shows the geographic impact of J. Kerdraon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kerdraon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kerdraon more than expected).

Fields of papers citing papers by J. Kerdraon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kerdraon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kerdraon. The network helps show where J. Kerdraon may publish in the future.

Co-authorship network of co-authors of J. Kerdraon

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kerdraon. A scholar is included among the top collaborators of J. Kerdraon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kerdraon. J. Kerdraon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fortin-Bédard, Noémie, Andréanne K. Blanchette, Laurent J. Bouyer, et al.. (2025). Acceptability of Overground Wearable Powered Exoskeletons for People with Spinal Cord Injury: A Multicenter Qualitative Study. Biomimetics. 10(1). 36–36.
2.
Peyronnet, B., Marianne de Sèze, A. Even, et al.. (2024). How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity. Neurourology and Urodynamics. 43(4). 811–817. 2 indexed citations
3.
Cousson‐Gélie, Florence, J. Kerdraon, D. Goossens, et al.. (2021). French cross-cultural adaptation and validity of the Moorong Self-Efficacy scale: the MSES-FR, a measure of Self-Efficacy for French people with spinal cord injury. Disability and Rehabilitation. 44(25). 8066–8074. 3 indexed citations
4.
Manunta, A., et al.. (2020). Is transcutaneous tibial nerve stimulation as effective in both neurological and non-neurological patients?. European Urology Open Science. 19. e1081–e1082. 1 indexed citations
5.
6.
Peyronnet, B., Fei Gao, Charlène Brochard, et al.. (2019). Urologic Disorders are Still the Leading Cause of In-hospital Death in Patients With Spina Bifida. Urology. 137. 200–204. 15 indexed citations
7.
Rémy‐Néris, Olivier, Djamel Bensmaïl, Walter Daveluy, et al.. (2018). Rehabilitation robotics of the upper limb after stroke. The REM_AVC trial. Annals of Physical and Rehabilitation Medicine. 61. e21–e21. 3 indexed citations
8.
Hascoët, J., A. Manunta, Solène‐Florence Kammerer‐Jacquet, et al.. (2017). Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review. Neurourology and Urodynamics. 37(3). 916–925. 10 indexed citations
9.
Mathieu, Laurence, B. Peyronnet, Sébastien Fontaine, et al.. (2017). Résultats de la neurostimulation tibiale postérieure transcutanée pour hyperactivité vésicale chez les patients diabétiques. Progrès en Urologie. 27(17). 1091–1097. 2 indexed citations
10.
Kerdraon, J., B. Peyronnet, X. Gamé, et al.. (2017). Physiopathologie de l’hypoactivité détrusorienne de la personne âgée. Progrès en Urologie. 27(7). 402–412. 3 indexed citations
11.
Peyronnet, B., R. Boissier, A. Manunta, et al.. (2017). Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourology and Urodynamics. 37(1). 291–297. 18 indexed citations
12.
Hascoët, J., A. Manunta, Charlène Brochard, et al.. (2016). Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review. 2 indexed citations
13.
Brochard, Charlène, A. Manunta, J. Kerdraon, et al.. (2016). Routine enema before urodynamics has no impact on the quality of abdominal pressure curves: Results of a prospective controlled study. Progrès en Urologie. 26(17). 1200–1205. 1 indexed citations
14.
Kerdraon, J., G. Robain, C. Jeandel, et al.. (2014). Traitement anticholinergique de l’hyperactivité vésicale de la personne âgée et ses impacts sur la cognition. Revue de la littérature. Progrès en Urologie. 24(11). 672–681. 17 indexed citations
15.
16.
Sèze, M. de, P. Denys, G. Karsenty, et al.. (2008). Suivi des patients après injection de toxine botulique intradétrusorienne Recommandations de bonne pratique clinique chez le patient neurologique. 51(4). 315–321. 7 indexed citations
17.
Karsenty, G., P. Denys, G. Amarenco, et al.. (2007). Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review. European Urology. 53(2). 275–287. 247 indexed citations
18.
Amarenco, G., et al.. (2001). Electrophysiological analysis of pudendal neuropathy following traction. Muscle & Nerve. 24(1). 116–119. 43 indexed citations
19.
Amarenco, G. & J. Kerdraon. (2000). Clinical value of ipsi- and contralateral sacral reflex latency measurement: A normative data study in man. Neurourology and Urodynamics. 19(5). 565–576. 23 indexed citations
20.
Amarenco, G., P. Denys, & J. Kerdraon. (1992). Neuropathie d'étirement du nerf honteux interne et incontinence urinaire féminine.. 98(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samer Sheikh Ismaël Breakdown of academic impact, for papers by Richard Baverstock Breakdown of academic impact, for papers by H.E. Dijkema Breakdown of academic impact, for papers by Marianne de Sèze Breakdown of academic impact, for papers by Rose Khavari Breakdown of academic impact, for papers by F. Le Breton Breakdown of academic impact, for papers by J.-J. Labat Breakdown of academic impact, for papers by Ubi van den Hombergh Breakdown of academic impact, for papers by M Perrigot Breakdown of academic impact, for papers by G. Krämer
Rankless by CCL
2026